Risk scoring system for predicting breast conservation after neoadjuvant chemotherapy.


Journal

The breast journal
ISSN: 1524-4741
Titre abrégé: Breast J
Pays: United States
ID NLM: 9505539

Informations de publication

Date de publication:
07 2019
Historique:
received: 10 02 2018
revised: 06 09 2018
accepted: 10 09 2018
pubmed: 9 5 2019
medline: 15 1 2020
entrez: 9 5 2019
Statut: ppublish

Résumé

We developed a risk scoring system (RSS) for predicting breast conservative surgery (BCS) in women receiving neoadjuvant chemotherapy(NAC) for breast cancer. BCS rate in the training set was 32.6%, associated with five variables: age < 50years, primary radiological tumor diameter < 60mm, absence of multifocality, absence of breast inflammation and hormone receptor status. These variables were assigned scores ranging from 0 to 9. The discrimination of the RSS was 0.78(95%CI 0.69-0.86) in the training set. The area under the curve of the receiver operating characteristics for predicting BCS after internal and external validation was 0.77(95%CI 0.68-0.85) and 0.75(95%CI 0.66-0.84), respectively.

Identifiants

pubmed: 31066151
doi: 10.1111/tbj.13303
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

696-701

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Lobna Ouldamer (L)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France.
INSERM U1069, Université François-Rabelais, Tours, France.

Sofiane Bendifallah (S)

Department of Gynaecology, Hôpital Tenon, Paris, France.
INSERM UMR S 938, Université Pierre et Marie Curie, Paris, France.

Joseph Pilloy (J)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France.

Flavie Arbion (F)

Department of Pathology, Centre Hospitalier Universitaire de Tours, France.

Gilles Body (G)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France.
INSERM U1069, Université François-Rabelais, Tours, France.

Caroline Brisson (C)

Department of Gynecology, Centre Hospitalier Universitaire de Tours, Tours, France.
INSERM U1069, Université François-Rabelais, Tours, France.

Vincent Lavoué (V)

Department of Gynaecology, CHU Anne de Bretagne, Rennes, France.

Jean Lévêque (J)

Department of Gynaecology, CHU Anne de Bretagne, Rennes, France.

Emile Daraï (E)

Department of Gynaecology, Hôpital Tenon, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH